Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening.

[1]  K. Iseki,et al.  An epidemiologic analysis of end-stage lupus nephritis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  W. Mitch,et al.  A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.

[3]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[4]  J. Velosa,et al.  Idiopathic membranous nephropathy: the natural history of untreated patients. , 1988, Kidney international.

[5]  J. Miller,et al.  Chronic progressive renal disease: rate of change of serum creatinine concentration. , 1977, Kidney international.

[6]  I. Ichikawa,et al.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. , 1995, The Journal of clinical investigation.

[7]  K. Iseki,et al.  Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. , 1993, Kidney international.

[8]  G. D'Amico,et al.  Clinical features and natural history in adults with IgA nephropathy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[10]  W. O'Fallon,et al.  Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. , 1989, Annals of internal medicine.

[11]  S. Zeger,et al.  The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. , 1984, The New England journal of medicine.

[12]  M. Black.  Letter: Cryostat sections in immunological studies of cancer. , 1973, Lancet.

[13]  N. Gretz,et al.  Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  P. Whelton,et al.  Hypertension as a Risk Factor for Renal Disease Review of Clinical and Epidemiological Evidence , 1989, Hypertension.

[15]  W. Kannel,et al.  The prognostic significance of proteinuria: the Framingham study. , 1984, American heart journal.

[16]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[17]  P. Brazy,et al.  Progressive renal disease: role of race and antihypertensive medications. , 1990, Kidney international.

[18]  K. Iseki,et al.  Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). , 1993, Kidney international.

[19]  A. Krolewski,et al.  The changing natural history of nephropathy in type I diabetes. , 1985, The American journal of medicine.

[20]  J. Bergström,et al.  Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. , 1986, Clinical nephrology.

[21]  J. Hopper,et al.  Membranous nephropathy: its relative benignity in women. , 1981, Nephron.

[22]  A. Hull,et al.  Introduction and summary. Proceedings from the Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, Tx, September 15 to 17, 1989. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  W. J. Johnson,et al.  Survival rates of 2,728 patients with end-stage renal disease. , 1984, Mayo Clinic proceedings.

[24]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[25]  K. Iseki,et al.  Epidemiologic analysis of diabetic patients on chronic dialysis. , 1996, Nephron.

[26]  S. Takishita,et al.  An Epidemiological Analysis of Cardiovascular Diseases in Okinawa, Japan , 1992 .

[27]  K. Iseki,et al.  Risk of developing end-stage renal disease in a cohort of mass screening. , 1996, Kidney international.

[28]  S. Takebayashi,et al.  Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. , 1987, Clinical nephrology.

[29]  D. Churchill,et al.  Canadian Hemodialysis Morbidity Study. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  B. Brenner,et al.  Short stature and diabetic nephropathy , 1995, BMJ.

[31]  B. Brenner,et al.  Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  S. Silbiger,et al.  The impact of gender on the progression of chronic renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[34]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[35]  K. Iseki,et al.  Serum albumin is a strong predictor of death in chronic dialysis patients. , 1993, Kidney international.